Tüm alıştırma soruları

8270 soru

Soru 2101Soru →

A pediatrician is reviewing normal child development principles to prepare for upcoming well-child examinations. To properly screen for developmental delays, clinicians must understand the normal sequencing of skills across various domains. Arrange the following pediatric developmental milestones in chronological order from earliest to latest based on the typical age of acquisition in a healthy, full-term child.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: Transfers an object from one hand to the other (6 months) → Demonstrates object permanence (9 months) → Uses a mature pincer grasp (12 months) → Combines vocabulary to form two-word phrases (24 months) → Walks up stairs using alternating feet (36 months).
Normal childhood development follows a predictable chronological progression across multiple domains. Fine motor skills advance from simple hand-to-hand transfer at 6 months to a highly coordinated mature pincer grasp by 12 months. Cognitive milestones like object permanence emerge around 9 months as the infant's memory capacity grows. Expressive language expands significantly in the second year, culminating in two-word phrases by 24 months. Advanced gross motor balance, such as ascending stairs with alternating feet, is typically achieved by 36 months.

Adım Adım Çözüm

1
Identify the typical age for transferring an object between hands.
6 months of age.
At 6 months, infants typically develop the bilateral coordination required to pass a small object from one hand to the other.
2
Identify the typical age for demonstrating object permanence.
9 months of age.
Object permanence, the cognitive understanding that an object continues to exist even when hidden from view, classically develops around 9 months. This coincides with the onset of stranger anxiety.
3
Identify the typical age for utilizing a mature pincer grasp.
12 months of age.
An infant progresses from an immature pincer grasp (using the pads of the thumb and side of the index finger) at 9 months to a mature pincer grasp (using the fingertips) by 12 months.
4
Identify the typical age for combining words into phrases.
24 months of age.
By 2 years (24 months), toddlers typically have a vocabulary of at least 50 words and begin combining them into simple two-word phrases (e.g., 'want milk').
5
Identify the typical age for walking up stairs with alternating feet.
36 months of age.
By 3 years (36 months), children develop sufficient balance and coordination to walk up stairs using alternating feet. (Note: walking down stairs with alternating feet typically occurs later, at 48 months).
6
Sequence the identified milestones in chronological order.
6 months → 9 months → 12 months → 24 months → 36 months.
This establishes the proper timeline of normal neurodevelopmental progression.

Anahtar Kavram

Chronological acquisition of normal pediatric developmental milestones
Tahmini Süre:1m 0s
Soru 2102Soru →

Match each biologic disease-modifying antirheumatic drug (bDMARD) with its specific mechanism of action and the most characteristic clinical caveat or adverse effect associated with its use.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Rituximab
Tocilizumab
Abatacept
Anakinra
Secukinumab

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Rituximab depletes CD20 and risks HBV reactivation; Tocilizumab inhibits IL-6 and risks GI perforation; Abatacept blocks CD80/86 and risks COPD exacerbation; Anakinra inhibits IL-1 and requires daily injections; Secukinumab neutralizes IL-17A and risks IBD exacerbation.
Each biologic DMARD has a distinct mechanism of action and a unique adverse effect profile that dictates pre-treatment screening and patient selection. Rituximab (anti-CD20) risks HBV reactivation. Tocilizumab (anti-IL-6R) is associated with dyslipidemia and GI perforations. Abatacept (CTLA-4-Ig) can exacerbate COPD. Anakinra (IL-1RA) has a short half-life requiring daily dosing. Secukinumab (anti-IL-17A) can precipitate or worsen inflammatory bowel disease.

Adım Adım Çözüm

1
Analyze the mechanism and adverse effects of Rituximab.
Rituximab targets CD20 on B cells. A classic and severe complication is hepatitis B reactivation, necessitating prior screening.
Identifying the target and its black-box warnings isolates the correct match.
2
Analyze the mechanism and adverse effects of Tocilizumab.
Tocilizumab targets the IL-6 receptor. It is uniquely associated with dyslipidemia and an increased risk of lower GI perforation, particularly in patients with diverticular disease.
IL-6 blockade has distinct metabolic and tissue-healing effects.
3
Analyze the mechanism and adverse effects of Abatacept.
Abatacept blocks T-cell costimulation via CD80/86. It has a specific warning for use in patients with underlying COPD due to increased respiratory exacerbations.
Costimulation blockade has specific pulmonary caveats.
4
Analyze the mechanism and adverse effects of Anakinra.
Anakinra is an IL-1 receptor antagonist. Its recombinant protein structure gives it a short half-life, requiring daily dosing.
Dosing frequency is a unique clinical caveat among biologics.
5
Analyze the mechanism and adverse effects of Secukinumab.
Secukinumab targets IL-17A. Because IL-17 maintains gut mucosal integrity, its blockade can induce or worsen Crohn disease and ulcerative colitis.
Understanding the physiological role of IL-17 explains its contraindication in IBD.

Anahtar Kavram

The mechanisms of action and highly specific adverse effect profiles of biologic disease-modifying antirheumatic drugs (bDMARDs).
Soru 2103Soru →

A 74-year-old man is admitted to the intensive care unit with septic shock secondary to a severe complicated urinary tract infection. He has a history of neurogenic bladder managed with clean intermittent catheterization. On admission, his temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 82/50 mmHg82/50\text{ mmHg}, and heart rate is 118/min118/\text{min}. He receives aggressive fluid resuscitation and is started on empiric intravenous piperacillin-tazobactam and vancomycin. By hospital day 3, his condition has significantly improved; he is afebrile, hemodynamically stable off vasopressors, and transferred to the general medical floor. Blood cultures and a urine culture obtained on admission both yield *Enterococcus faecalis*. Susceptibility testing indicates the organism is sensitive to ampicillin, vancomycin, linezolid, and daptomycin, but intrinsically resistant to cephalosporins. Which of the following is the most appropriate next step in pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Discontinue the current regimen and begin intravenous ampicillin

Cevap

Discontinue the current regimen and begin intravenous ampicillin
Intravenous ampicillin is the drug of choice for susceptible Enterococcus faecalis. The cornerstone of antimicrobial stewardship is de-escalation: once a patient who initially required empiric broad-spectrum antibiotics (for conditions like septic shock) stabilizes and specific susceptibility data returns, the regimen must be narrowed to the most targeted agent available. Ampicillin provides excellent bactericidal activity against susceptible enterococci without the unnecessary broad-spectrum gram-negative, anaerobic, or MRSA coverage provided by the empiric regimen.

Adım Adım Çözüm

1
Evaluate the patient's clinical trajectory and culture data.
The patient has stabilized from septic shock, and cultures have identified Enterococcus faecalis as the sole pathogen.
Clinical stability and pathogen identification mandate transitioning from empiric to definitive targeted therapy.
2
Analyze the susceptibility profile of the isolated pathogen.
The isolate is susceptible to multiple agents, including ampicillin, vancomycin, linezolid, and daptomycin.
To select the most effective agent with the narrowest possible spectrum.
3
Apply antimicrobial stewardship principles to select definitive therapy.
Ampicillin is selected to replace the broad-spectrum piperacillin-tazobactam and vancomycin.
Ampicillin is the gold-standard, targeted therapy for susceptible E. faecalis, minimizing collateral microbiome damage and preventing resistance.

Anahtar Kavram

Once a patient stabilizes and culture sensitivities are available, empiric broad-spectrum antibiotics must be de-escalated to the narrowest effective targeted therapy (e.g., ampicillin for susceptible E. faecalis) to practice proper antimicrobial stewardship.
Soru 2104Soru →

A 54-year-old man develops severe pain, redness, and swelling of his right big toe on postoperative day 3 following an uncomplicated laparoscopic cholecystectomy. He cannot bear weight on the affected foot. His temperature is 37.6°C (99.7°F), blood pressure is 135/85 mm Hg, and pulse is 88/min. Examination shows an exquisitely tender, erythematous, and swollen right first metatarsophalangeal joint. Synovial fluid analysis reveals a leukocyte count of 22,000/mm³ and numerous negatively birefringent, needle-shaped crystals. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Administer oral indomethacin

Cevap

Administer oral indomethacin
The correct answer is to administer an NSAID such as oral indomethacin. This patient presents with a classic acute gout flare (podagra), commonly precipitated by the physiological stress of surgery, changes in diet, or fluctuations in fluid status during hospitalization. The diagnosis is definitively established by the presence of negatively birefringent, needle-shaped monosodium urate crystals in the synovial fluid. The primary goal in acute gout management is the rapid reduction of inflammation, which is achieved through the use of NSAIDs, colchicine, or intra-articular/systemic corticosteroids.

Adım Adım Çözüm

1
Analyze the clinical presentation and synovial fluid results.
The patient has an acute monoarthritis on postoperative day 3. The synovial fluid analysis demonstrates a moderately elevated leukocyte count with negatively birefringent, needle-shaped crystals.
Identifying the specific crystal characteristics is required to differentiate gout from other forms of acute arthritis, such as pseudogout or septic arthritis.
2
Synthesize the findings to establish a definitive diagnosis.
The clinical picture is diagnostic for an acute gout flare (podagra), which is frequently triggered by the physiological stress of recent surgery or hospitalization.
Establishing the correct etiology of the joint inflammation dictates the appropriate choice of pharmacotherapy.
3
Determine the most appropriate initial treatment for the diagnosed condition.
Nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin, colchicine, or systemic corticosteroids are the appropriate first-line agents for an acute gout flare.
Acute gout requires rapid anti-inflammatory therapy. Urate-lowering medications should generally be avoided in the acute setting if the patient is not already taking them.

Anahtar Kavram

The diagnosis and acute management of a gout flare.
Soru 2105Soru →

A 58-year-old female patient visits the outpatient clinic to discuss a two-month history of progressively worsening shortness of breath. Initially, she noticed breathlessness only when climbing stairs, but she now experiences it after walking short distances on level ground. The patient's medical background is notable for limited cutaneous systemic sclerosis, characterized by diffuse calcinosis cutis, severe esophageal dysmotility, and tightening of the skin over her fingers. She also has a history of primary hypothyroidism and severe digital vasospasm triggered by cold exposure.

Her daily medications include amlodipine, omeprazole, levothyroxine, and sildenafil.

Vital signs are as follows:
- Temperature: 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F})
- Blood pressure: 126/78 mm Hg126/78\text{ mm Hg}
- Heart rate: 94/min94/\text{min}
- Respiratory rate: 22/min22/\text{min}
- Pulse oximetry: 94%94\% on room air

Physical examination reveals clear lung fields bilaterally with no crackles or wheezes. Cardiovascular assessment demonstrates a prominent parasternal impulse and a markedly accentuated pulmonic component of the second heart sound. Examination of the lower extremities shows mild bilateral pitting edema.

Recent laboratory and diagnostic results:

TestResultReference Range
TSH7.4 μU/mL7.4\text{ }\mu\text{U/mL}0.4−4.0 μU/mL0.4-4.0\text{ }\mu\text{U/mL}
Free T41.2 ng/dL1.2\text{ ng/dL}0.8−1.8 ng/dL0.8-1.8\text{ ng/dL}
BNP450 pg/mL450\text{ pg/mL}<100 pg/mL<100\text{ pg/mL}

An electrocardiogram reveals right axis deviation and signs of right ventricular hypertrophy. A chest radiograph demonstrates prominent central pulmonary arteries with rapid peripheral tapering and completely clear lung parenchyma. A transthoracic echocardiogram obtained yesterday estimates a right ventricular systolic pressure of 55 mm Hg55\text{ mm Hg} with normal left ventricular ejection fraction.

Which of the following is the most appropriate next step in the evaluation of this patient's current presentation?

Cevabı ve açıklamayı göster

Cevap: Perform right heart catheterization

Cevap

Perform right heart catheterization
The correct next step is to perform right heart catheterization. This patient's history of limited cutaneous systemic sclerosis (CREST syndrome) combined with exertional dyspnea, a parasternal heave, an accentuated P2, and an elevated right ventricular systolic pressure on echocardiography strongly points to pulmonary arterial hypertension (PAH). While transthoracic echocardiography is the appropriate initial screening test (which she has already undergone), right heart catheterization is mandatory to definitively establish the diagnosis of PAH. It accomplishes this by demonstrating a mean pulmonary arterial pressure (mPAP) > 20 mm Hg20\text{ mm Hg} and a pulmonary capillary wedge pressure (PCWP) <= 15 mm Hg15\text{ mm Hg}. Confirming these hemodynamics is strictly required before initiating advanced pulmonary vasodilator therapies such as endothelin receptor antagonists or prostacyclin analogs.

Adım Adım Çözüm

1
Identify the primary clinical syndrome from the patient's history and physical exam.
The patient has progressive exertional dyspnea, a parasternal heave, a loud P2, and lower extremity edema with clear lungs, strongly suggesting right-sided heart failure secondary to pulmonary hypertension.
Correlating physical exam findings with the history of limited cutaneous systemic sclerosis points toward Pulmonary Arterial Hypertension (PAH), a classic and leading cause of mortality in this population.
2
Evaluate the diagnostic workup provided in the vignette.
The chest X-ray and ECG support right heart strain. The transthoracic echocardiogram (TTE) confirms an elevated right ventricular systolic pressure (55 mm Hg55\text{ mm Hg}), providing a positive screening result for PAH.
TTE is the initial screening test of choice for suspected pulmonary hypertension, but it cannot definitively diagnose the condition or rule out occult left-sided heart disease.
3
Determine the required intervention to establish a definitive diagnosis before treatment.
Right heart catheterization must be performed.
Right heart catheterization definitively confirms pre-capillary PAH by demonstrating a mean pulmonary arterial pressure (mPAP) > 20 mm Hg20\text{ mm Hg} and a pulmonary capillary wedge pressure (PCWP) <= 15 mm Hg15\text{ mm Hg}. This is mandatory before starting advanced pulmonary vasodilator therapies.

Anahtar Kavram

Pulmonary Arterial Hypertension (PAH) is a major complication of systemic sclerosis; while echocardiography is the best initial screening tool, right heart catheterization is required for definitive diagnosis.
Soru 2106Soru →

An otherwise healthy 45-year-old woman receives treatment in the inpatient ward for an acute complicated urinary tract infection with associated bacteremia. At the time of admission two days ago, she presented with fever, chills, and costovertebral angle tenderness, prompting the initiation of empiric intravenous piperacillin-tazobactam. Today, she has been afebrile for the past 24 hours, her flank pain has nearly resolved, and she is tolerating a regular diet. Final culture results from both blood and urine demonstrate growth of *Escherichia coli*. The susceptibility report indicates resistance to ampicillin, but susceptibility to ceftriaxone, trimethoprim-sulfamethoxazole, levofloxacin, and piperacillin-tazobactam. Based on the culture results and the patient's clinical improvement, what is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Transition to oral trimethoprim-sulfamethoxazole

Cevap

Transition to oral trimethoprim-sulfamethoxazole
The correct answer is to transition the patient to oral trimethoprim-sulfamethoxazole. The patient is clinically stable, afebrile, and tolerating an oral diet, which meets the criteria for transitioning from intravenous to oral antibiotics. Furthermore, proper antibiotic stewardship dictates de-escalating from broad-spectrum empiric coverage (like piperacillin-tazobactam) to a narrower-spectrum, targeted agent based on culture and susceptibility data. Trimethoprim-sulfamethoxazole has excellent oral bioavailability and the patient's isolate is explicitly susceptible to it.

Adım Adım Çözüm

1
Evaluate the patient's clinical status for transition to oral therapy.
The patient is afebrile, improving, and tolerating an oral diet.
Clinical stability and the ability to take medications by mouth are the primary indications for safely switching from intravenous to oral antibiotics.
2
Analyze the culture and susceptibility data to select a targeted antimicrobial agent.
The Escherichia coli isolate is susceptible to several narrower-spectrum agents, including trimethoprim-sulfamethoxazole.
Antimicrobial stewardship guidelines mandate de-escalating from broad-spectrum empiric therapy to the narrowest effective agent once sensitivities are known.
3
Select the most appropriate oral antibiotic for step-down therapy.
Oral trimethoprim-sulfamethoxazole is chosen over intravenous options.
It provides targeted coverage against the susceptible isolate and has excellent oral bioavailability, allowing for safe completion of the treatment course.

Anahtar Kavram

Antibiotic stewardship and de-escalation of antimicrobial therapy
Soru 2107Soru →

Emergency medical personnel transport an elderly resident from an assisted living facility to the acute medical unit. The staff reported a three-day decline in functional status, noting increased thirst, frequent urination, and an escalating, non-productive cough. Medical records indicate long-standing insulin-requiring diabetes mellitus and severe chronic obstructive pulmonary disease.

Upon arrival, the patient is somnolent but appropriately follows simple commands. Vital signs reveal a temperature of 37.0°C (98.6°F), heart rate of 118/min, blood pressure of 105/62 mm Hg, and a respiratory rate of 28/min with shallow, labored breathing. Oxygen saturation is 90% on ambient air. Physical examination demonstrates poor skin turgor, prominent use of accessory muscles of respiration, and diffuse expiratory wheezing with a prolonged expiratory phase. Jugular venous pressure is estimated at 4 cm H2O.

Initial laboratory studies are obtained:

TestResult
Serum sodium134 mEq/L
Serum potassium4.9 mEq/L
Serum chloride96 mEq/L
Serum bicarbonate12 mEq/L
Blood urea nitrogen42 mg/dL
Serum creatinine1.8 mg/dL
Serum glucose540 mg/dL

Arterial blood gas analysis on ambient air:

TestResult
pH7.15
PaCO238 mm Hg
PaO265 mm Hg

In addition to intravenous fluid resuscitation and a continuous regular insulin infusion, which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Initiation of noninvasive positive pressure ventilation

Cevap

The most appropriate next step is the initiation of noninvasive positive pressure ventilation to address the impending respiratory failure.
The correct answer identifies that this patient is suffering from two concurrent, life-threatening pathologies: diabetic ketoacidosis (DKA) and an acute exacerbation of COPD leading to respiratory failure. The diagnosis of the mixed acid-base disorder hinges on Winter's formula (PaCO2=1.5×[HCO3−]+8±2PaCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2). With a serum bicarbonate of 12 mEq/L, her expected PaCO2PaCO_2 should be between 24 and 28 mm Hg. Because her actual PaCO2PaCO_2 is 38 mm Hg, she has a superimposed respiratory acidosis. In a patient with severe COPD presenting with tachypnea, use of accessory muscles, and somnolence, this relative hypercapnia represents severe respiratory muscle fatigue. While the DKA is being managed with fluids and insulin, the immediate life-threatening respiratory failure must be addressed with noninvasive positive pressure ventilation (NIPPV).

Adım Adım Çözüm

1
Calculate the anion gap to determine the primary metabolic disorder.
Anion Gap = 134−(96+12)=26134 - (96 + 12) = 26.
An elevated anion gap (>12>12) confirms a primary metabolic acidosis, consistent with the clinical picture of diabetic ketoacidosis (DKA).
2
Apply Winter's formula to determine if respiratory compensation is adequate.
Expected PaCO2=1.5×12+8±2=26±2PaCO_2 = 1.5 \times 12 + 8 \pm 2 = 26 \pm 2 mm Hg (range 24-28).
To identify mixed acid-base disorders, the expected compensatory PaCO2 must be compared to the measured PaCO2.
3
Compare the expected PaCO2 to the measured PaCO2 from the arterial blood gas.
The measured PaCO2PaCO_2 is 38 mm Hg, which is significantly higher than the expected maximum of 28 mm Hg.
When the measured PaCO2 is higher than the expected value, a concurrent primary respiratory acidosis is present.
4
Correlate the laboratory findings with the clinical examination.
The patient has a history of severe COPD, is using accessory muscles, and is somnolent despite tachypnea.
A "normal" PaCO2 of 38 mm Hg in the setting of severe metabolic acidosis indicates respiratory muscle fatigue and impending respiratory failure. Noninvasive positive pressure ventilation (NIPPV) is the appropriate intervention to provide ventilatory support.

Anahtar Kavram

In patients with a primary metabolic acidosis, a 'normal' PaCO2 on arterial blood gas often indicates a failure of respiratory compensation and a concurrent respiratory acidosis, signaling impending respiratory failure that requires ventilatory support.
Tahmini Süre:2m 0s
Soru 2108Soru →

A 2525-year-old man presents to the clinic with a diffuse maculopapular rash on his trunk, palms, and soles, along with generalized lymphadenopathy. He reports having a painless penile ulcer 22 months ago that resolved on its own. Assuming the traditional testing algorithm is used, arrange the following steps in the most appropriate chronological sequence for the diagnosis and management of this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence for the traditional syphilis management algorithm is: initial screening with a nontreponemal test, followed by confirmation with a treponemal test, targeted treatment with intramuscular benzathine penicillin G, and finally, monitoring for a cure using serial quantitative nontreponemal titers.
The traditional algorithm for diagnosing and managing syphilis follows a strict chronological order. It begins with a nontreponemal test (such as RPR or VDRL) for initial screening. Because these tests have high false-positive rates, any positive result must be confirmed with a specific treponemal test (such as FTA-ABS or TP-PA). Once confirmed, the patient is formally diagnosed with secondary syphilis and treated with the standard regimen: intramuscular benzathine penicillin G. To ensure the treatment was effective and the patient is cured, quantitative nontreponemal titers must be monitored at 66 and 1212 months to observe at least a fourfold decline.

Adım Adım Çözüm

1
Identify the suspected disease based on the patient's clinical presentation.
The patient's diffuse maculopapular rash involving the palms and soles, preceded by a painless ulcer (chancre), is classic for secondary syphilis.
Recognizing the clinical stage of the infection guides the subsequent diagnostic and therapeutic approach.
2
Determine the first diagnostic step in the traditional testing algorithm.
The first step is to order a nontreponemal screening test, such as the Rapid Plasma Reagin (RPR) or Venereal Disease Research Laboratory (VDRL) test.
These tests are highly sensitive and inexpensive, making them ideal for initial population screening, though they lack specificity.
3
Determine the necessary follow-up for a positive screening test.
A treponemal confirmatory test, such as Fluorescent Treponemal Antibody Absorption (FTA-ABS) or *Treponema pallidum* particle agglutination (TP-PA), must be performed.
Because nontreponemal tests can yield false-positive results due to cross-reactivity from other conditions, confirmation with a highly specific treponemal test is required before making a definitive diagnosis.
4
Determine the appropriate therapy once the diagnosis of syphilis is confirmed.
The treatment of choice is a single dose of intramuscular benzathine penicillin G.
Penicillin G is the definitive, highly effective first-line treatment for primary, secondary, and early latent syphilis.
5
Determine the appropriate post-treatment follow-up management.
Serial quantitative nontreponemal testing is performed at 66 and 1212 months.
A fourfold decrease in the nontreponemal titer is required to objectively confirm that the treatment was successful.

Anahtar Kavram

The traditional diagnostic algorithm for syphilis requires initial screening with a sensitive nontreponemal test, confirmation with a specific treponemal test, targeted treatment with penicillin, and follow-up monitoring of nontreponemal titers.
Tahmini Süre:1m 0s
Soru 2109Soru →

A 55-year-old man receiving systemic chemotherapy for diffuse large B-cell lymphoma presents to the emergency department with chills and a temperature of 38.8°C (101.8°F). His laboratory evaluation reveals an absolute neutrophil count of 400/mm³. Arrange the following clinical interventions in the correct chronological sequence for the standard initial management of this patient's neutropenic fever.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Obtain blood cultures, followed by administration of empiric broad-spectrum antibiotics, then monitor clinically while awaiting results, and finally narrow the antimicrobial regimen once susceptibilities are known.
The standard of care for febrile neutropenia requires obtaining cultures first so that the causative organism can be identified. Immediately after cultures are drawn, empiric broad-spectrum antibiotics covering Pseudomonas aeruginosa must be given to prevent overwhelming sepsis. The patient is then monitored, and antibiotics are de-escalated to targeted therapy only after specific culture and susceptibility results return.

Adım Adım Çözüm

1
Recognize the clinical scenario as neutropenic fever.
The patient has a fever and an absolute neutrophil count < 500/mm³, defining a hematologic/oncologic emergency.
Prompt recognition dictates the urgency of subsequent interventions.
2
Identify the critical first intervention before administering medications.
Blood cultures (both peripheral and central) must be drawn first.
Administering antibiotics before drawing cultures can sterilize the blood samples, preventing the identification of the infecting organism.
3
Determine the next immediate life-saving step.
Administer empiric broad-spectrum intravenous antibiotics (e.g., cefepime).
Patients lack an adequate immune response; delaying antibiotics can lead to rapid clinical deterioration and sepsis.
4
Determine the subsequent hospital course sequence.
Observation and monitoring follow the initial acute resuscitation, leading finally to regimen de-escalation once lab results finalize.
Therapy must be tailored later to prevent antimicrobial resistance and reduce medication toxicity.

Anahtar Kavram

In the management of neutropenic fever, blood cultures must be drawn immediately, followed by the rapid administration of broad-spectrum antipseudomonal antibiotics within one hour of presentation, prior to narrowing therapy based on culture results.
Soru 2110Soru →

During a routine follow-up evaluation, a 32-year-old woman with diffuse cutaneous systemic sclerosis reports severe pain and discoloration in her digits. She notes that exposure to cold temperatures triggers her fingers to turn sharply white, then blue, and finally red. Arrange the following therapeutic interventions in the correct step-wise sequence for the management of this patient's Raynaud phenomenon, proceeding from initial conservative measures to therapies reserved for severe, refractory, or tissue-threatening disease.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing secondary Raynaud phenomenon is: non-pharmacologic lifestyle modifications, followed by oral calcium channel blockers, followed by phosphodiesterase-5 inhibitors, and finally intravenous prostanoids for severe tissue-threatening disease.
The standard of care for secondary Raynaud phenomenon involves a precise step-wise escalation. It begins unconditionally with conservative lifestyle modifications, primarily avoiding cold triggers, ensuring whole-body warming, and smoking cessation. If these measures fail to adequately control the frequency or severity of attacks, first-line medical therapy is initiated with dihydropyridine calcium channel blockers (such as nifedipine or amlodipine). Should the patient remain highly symptomatic despite maximally tolerated doses of CCBs, second-line oral agents such as phosphodiesterase-5 inhibitors (e.g., sildenafil) or topical nitrates are added. Finally, for severe, refractory cases presenting with critical digital ischemia or active digital ulcerations, advanced therapies like intravenous prostanoid analogs (iloprost) or endothelin receptor antagonists (bosentan) are utilized.

Adım Adım Çözüm

1
Identify the primary clinical presentation.
The patient is presenting with classic triphasic color changes indicative of Raynaud phenomenon, secondary to systemic sclerosis.
Accurate identification of the syndrome dictates the appropriate treatment algorithm.
2
Determine the first-line conservative management.
Cold avoidance and smoking cessation.
All patients must begin with non-pharmacologic lifestyle modifications to minimize triggers before initiating medications.
3
Select the first-line pharmacologic therapy.
Dihydropyridine calcium channel blockers (e.g., nifedipine or amlodipine).
Calcium channel blockers are the standard initial medical therapy for symptomatic relief if lifestyle changes are inadequate.
4
Determine the step-up therapy for refractory symptoms.
Phosphodiesterase-5 inhibitors (e.g., sildenafil).
These agents promote further vasodilation and are indicated when calcium channel blockers alone fail to control symptoms.
5
Identify the intervention for severe, critical ischemia.
Intravenous prostanoids (e.g., iloprost or epoprostenol).
Because of significant side effects and required inpatient administration, these agents are strictly reserved for severe complications like digital ulcers.

Anahtar Kavram

Step-wise escalation of therapy for secondary Raynaud phenomenon.
Soru 2111Soru →

A daughter brings her 75-year-old father to the emergency department due to his profound sleepiness and labored breathing over the preceding 72 hours. The patient has developed a worsening cough productive of yellow sputum and subjective fevers during this time. His medical history includes chronic obstructive pulmonary disease (COPD), benign prostatic hyperplasia, and essential hypertension. His home medications are a tiotropium inhaler, as-needed albuterol, and amlodipine.

Vital signs show a temperature of 37.7∘C37.7^\circ\text{C} (99.9∘F99.9^\circ\text{F}), blood pressure of 118/74 mm Hg118/74\text{ mm Hg}, pulse of 108/min108/\text{min}, and respiratory rate of 26/min26/\text{min}. Pulse oximetry reveals an oxygen saturation of 85%85\% on room air.

Physical examination demonstrates a somnolent patient who awakens easily to verbal stimuli and follows simple commands. The anteroposterior chest diameter is increased. Auscultation reveals a prolonged expiratory phase with diffuse wheezing bilaterally, as well as coarse crackles localized to the right lower lung field. Cardiac examination shows a regular tachycardia with distant heart sounds and no murmurs. Trace bilateral ankle edema is present.

Laboratory results are as follows:

Laboratory TestResultReference Range
Leukocyte count14,500/mm314,500/\text{mm}^34,500–11,000/mm34,500\text{--}11,000/\text{mm}^3
Serum sodium136 mEq/L136\text{ mEq/L}136–145 mEq/L136\text{--}145\text{ mEq/L}
Serum potassium4.1 mEq/L4.1\text{ mEq/L}3.5–5.0 mEq/L3.5\text{--}5.0\text{ mEq/L}
Serum chloride94 mEq/L94\text{ mEq/L}98–106 mEq/L98\text{--}106\text{ mEq/L}
Serum bicarbonate35 mEq/L35\text{ mEq/L}22–28 mEq/L22\text{--}28\text{ mEq/L}
Blood urea nitrogen28 mg/dL28\text{ mg/dL}8–20 mg/dL8\text{--}20\text{ mg/dL}
Serum creatinine1.1 mg/dL1.1\text{ mg/dL}0.7–1.3 mg/dL0.7\text{--}1.3\text{ mg/dL}
Thyroid-stimulating hormone (TSH)0.2 μU/mL0.2\text{ }\mu\text{U/mL}0.4–4.0 μU/mL0.4\text{--}4.0\text{ }\mu\text{U/mL}
Free thyroxine (T4)0.7 ng/dL0.7\text{ ng/dL}0.9–1.7 ng/dL0.9\text{--}1.7\text{ ng/dL}

An arterial blood gas analysis obtained on room air demonstrates:

ParameterResult
pH\text{pH}7.257.25
PaO2\text{PaO}_252 mm Hg52\text{ mm Hg}
PaCO2\text{PaCO}_278 mm Hg78\text{ mm Hg}

A portable chest radiograph displays hyperinflated lung fields, flattened hemidiaphragms, and a dense alveolar opacity in the right lower lobe. The cardiac silhouette is normal in size.

Which of the following is the most appropriate next step in management for this patient?

Cevabı ve açıklamayı göster

Cevap: Initiate noninvasive positive-pressure ventilation and administer intravenous ceftriaxone and azithromycin

Cevap

The most appropriate next step is to initiate noninvasive positive-pressure ventilation (NPPV) and administer standard-spectrum antibiotics for community-acquired pneumonia (e.g., ceftriaxone and azithromycin).
This patient is experiencing an acute exacerbation of chronic obstructive pulmonary disease (COPD) complicated by acute-on-chronic hypercapnic respiratory failure, as evidenced by his pH of 7.25 and PaCO2 of 78 mm Hg. In patients with a COPD exacerbation and respiratory acidosis (pH < 7.30), a trial of noninvasive positive-pressure ventilation (NPPV) is the standard of care, provided the patient is not entirely comatose and can protect their airway (this patient awakens easily to verbal stimuli). Furthermore, the clinical picture of fever, purulent sputum, leukocytosis, and a right lower lobe consolidation indicates that community-acquired pneumonia (CAP) is the trigger. Standard inpatient treatment for CAP without risk factors for multidrug-resistant organisms includes a beta-lactam and a macrolide (e.g., ceftriaxone and azithromycin).

Adım Adım Çözüm

1
Analyze the arterial blood gas (ABG) and clinical presentation.
The ABG shows a pH of 7.25, PaCO2 of 78 mm Hg, and HCO3 of 35 mEq/L, indicating acute-on-chronic respiratory acidosis. The patient is somnolent but can protect his airway.
Identifying hypercapnic respiratory failure with a pH < 7.30 establishes the immediate need for ventilatory support, with NPPV being the first-line choice for conscious patients.
2
Identify the underlying trigger for the respiratory decompensation.
Fever, leukocytosis, and a right lower lobe opacity on the chest radiograph indicate community-acquired pneumonia (CAP) as the trigger for the COPD exacerbation.
Treating the underlying trigger is essential for resolving the exacerbation.
3
Select the appropriate pharmacologic and supportive therapies.
Standard CAP coverage (e.g., a beta-lactam plus a macrolide) is chosen. Broad-spectrum agents, diuretics, or thyroid hormones are excluded.
There are no risk factors for multidrug-resistant organisms, no evidence of acute heart failure, and the thyroid labs reflect euthyroid sick syndrome, which requires no treatment.

Anahtar Kavram

Management of acute-on-chronic respiratory acidosis in COPD exacerbations requires NPPV (if the patient can protect their airway) alongside targeted treatment of the underlying trigger (e.g., standard-spectrum antibiotics for community-acquired pneumonia).
Soru 2112Soru →

A 41-year-old woman is brought to the emergency department by her husband due to a 4-day history of profound fatigue, easy bruising, and recurrent nosebleeds. She has no significant past medical history and takes no medications. Vital signs show a temperature of 37.6∘C37.6^\circ \text{C} (99.7∘F99.7^\circ \text{F}), pulse of 110110/min, respirations of 1818/min, and blood pressure of 105/65105/65 mm Hg. Physical examination reveals pale mucous membranes, diffuse petechiae over the trunk and extremities, and continuous oozing of blood from a peripheral intravenous catheter site.

Laboratory studies reveal the following:

* Hemoglobin: 7.67.6 g/dL
* Leukocyte count: 3,200/μL3,200/\mu\text{L}
* Platelet count: 18,000/μL18,000/\mu\text{L}
* Prothrombin time: 2222 seconds
* Activated partial thromboplastin time: 4848 seconds
* Fibrinogen: 8080 mg/dL (Normal: 200200–400400 mg/dL)
* D-dimer: 8,5008,500 ng/mL (Normal: <500< 500 ng/mL)

Peripheral blood smear demonstrates large mononuclear cells with bilobed nuclei and abundant azurophilic granules; several of these cells contain multiple, needle-like eosinophilic inclusion bodies.

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Administration of all-trans retinoic acid

Cevap

Administration of all-trans retinoic acid
This patient's clinical presentation is highly characteristic of acute promyelocytic leukemia (APL) complicated by disseminated intravascular coagulation (DIC). The peripheral smear describes atypical promyelocytes containing multiple Auer rods, which are pathognomonic for APL. APL is unique among leukemias because it frequently presents with a severe, life-threatening coagulopathy (elevated PT/aPTT, low fibrinogen, elevated D-dimer). The most critical initial step in management is the immediate administration of all-trans retinoic acid (ATRA). ATRA overcomes the differentiation block caused by the PML-RARA fusion protein, allowing the neoplastic promyelocytes to mature into functional neutrophils. This rapidly resolves the coagulopathy and dramatically reduces the risk of fatal hemorrhagic complications, such as intracranial hemorrhage. Because early mortality is so high, ATRA must be started upon clinical suspicion alone, prior to genetic or bone marrow confirmation.

Adım Adım Çözüm

1
Analyze the patient's presentation and laboratory findings.
The patient has severe bleeding, pancytopenia, and a coagulation profile consistent with disseminated intravascular coagulation (DIC): prolonged PT/aPTT, low fibrinogen, and markedly elevated D-dimer.
Identifying DIC is critical as it indicates a life-threatening, systemic consumptive coagulopathy.
2
Interpret the peripheral blood smear results.
The presence of large mononuclear cells with bilobed nuclei and multiple needle-like eosinophilic inclusion bodies (Auer rods) indicates acute promyelocytic leukemia (APL).
Auer rods are specific for myeloblasts and promyelocytes; multiple Auer rods ('faggot cells') are pathognomonic for APL.
3
Determine the pathogenesis of the coagulopathy.
The abnormal promyelocytes contain azurophilic granules that, when released, activate the coagulation cascade leading to severe DIC.
Understanding the mechanism dictates why standard cytolytic chemotherapy would be acutely dangerous.
4
Prioritize interventions.
Select immediate administration of all-trans retinoic acid (ATRA) over obtaining a definitive bone marrow biopsy.
Because APL-associated DIC carries an exceptionally high risk of early hemorrhagic death (e.g., intracranial hemorrhage), targeted treatment (ATRA) must begin based on clinical and peripheral smear suspicion alone, without waiting for cytogenetic confirmation.

Anahtar Kavram

In patients with suspected acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) must be administered immediately—prior to bone marrow biopsy confirmation—to rapidly reverse the life-threatening coagulopathy of disseminated intravascular coagulation (DIC).
Tahmini Süre:1m 30s
Soru 2113Soru →

Correlate each complex clinical scenario with the specific autoantibody marker that best corresponds to the patient's underlying rheumatologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A previously healthy individual develops rapidly progressive, profound proximal weakness and severe dysphagia over three weeks. Laboratory analysis reveals a creatine kinase level of 14,500 U/L. Muscle biopsy demonstrates extensive necrotizing myopathy lacking prominent inflammatory infiltrates.
A patient evaluated for recent-onset extensive cutaneous induration across the trunk and proximal extremities presents to the emergency department with a severe headache, blurred vision, blood pressure of 215/115 mmHg, and a rapidly rising serum creatinine.
An individual presents with profound, generalized hand edema ('puffy fingers'), severe digital vasospasm upon cold exposure, and exertional breathlessness. Echocardiography estimates a right ventricular systolic pressure of 55 mm Hg with normal left ventricular function and no pulmonary parenchymal disease.
A patient describes difficulty rising from low chairs, persistent dry cough, and thickened, cracked, hyperkeratotic skin on the radial aspects of the digits. High-resolution computed tomography of the chest shows bilateral basilar ground-glass opacities.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct mappings associate immune-mediated necrotizing myopathy with anti-SRP, scleroderma renal crisis with anti-RNA polymerase III, Mixed Connective Tissue Disease with anti-U1-RNP, and antisynthetase syndrome with anti-Jo-1 antibodies.
Each autoantibody represents a distinct pathophysiologic entity within the rheumatologic spectrum. Anti-SRP mediates aggressive necrotizing myopathy. Anti-RNA polymerase III correlates with rapidly progressive diffuse systemic sclerosis and scleroderma renal crisis. Anti-U1-RNP defines Mixed Connective Tissue Disease with a high risk of pulmonary arterial hypertension. Anti-Jo-1 defines antisynthetase syndrome characterized by myositis, interstitial lung disease, and mechanic's hands.

Adım Adım Çözüm

1
Analyze the first clinical presentation featuring massive CK elevation and necrotizing biopsy without inflammation.
Identified as immune-mediated necrotizing myopathy.
Differentiates this aggressive pathology from classic polymyositis, which typically features prominent CD8+ T-cell endomysial inflammation.
2
Evaluate the patient with diffuse skin thickening and malignant hypertension.
Identified as diffuse cutaneous systemic sclerosis complicated by scleroderma renal crisis.
Requires recognition of the specific autoantibody (anti-RNA polymerase III) conveying the highest risk for this life-threatening renal complication.
3
Assess the presentation of puffy fingers, Raynaud's, and isolated pulmonary arterial hypertension.
Identified as Mixed Connective Tissue Disease (MCTD).
The lack of parenchymal lung disease combined with these specific overlapping connective tissue features points to MCTD rather than pure systemic sclerosis.
4
Review the triad of proximal weakness, interstitial lung disease, and hyperkeratotic fingers.
Identified as antisynthetase syndrome.
The skin findings represent 'mechanic's hands', which alongside ILD and myopathy, are pathognomonic for this specific overlap syndrome driven by anti-Jo-1.

Anahtar Kavram

Advanced serologic profiling in systemic autoimmune diseases, specifically differentiating unique autoantibodies in inflammatory myopathies and scleroderma-spectrum disorders.
Tahmini Süre:2m 30s
Soru 2114Soru →

Concerned about their son's lack of progress, a young couple schedules an evaluation for their firstborn child who just celebrated his fourth birthday. According to the parents, the child appears "clumsy" and struggles with fine motor tasks, specifically noting his inability to tie his shoelaces and his failure to draw a triangle when instructed by his preschool teacher. During the clinical observation, the boy successfully hops on one foot, independently buttons his shirt, copies a cross, and plays a board game cooperatively with his mother. His speech is fully intelligible, though he occasionally repeats the first syllables of words when enthusiastically describing his favorite toy. No facial tics or signs of physical struggle accompany these speech repetitions. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Provide reassurance and continue routine health surveillance

Cevap

Provide reassurance and continue routine health surveillance
The correct action is to provide reassurance and continue routine surveillance. This 4-year-old child is exhibiting completely age-appropriate development. Fine motor milestones for a 4-year-old include buttoning clothes, using scissors, and copying a cross or square. Tying shoelaces and copying a triangle are advanced milestones that are not expected until age 5. Gross motor skills (hopping on one foot) and social skills (cooperative play) are also well-aligned with the 4-year-old stage. Furthermore, the child's stuttering—characterized by repeating syllables without secondary signs of distress, tension, or facial tics—is highly consistent with benign developmental dysfluency. This is a common phenomenon in children between the ages of 2 and 5 as their expressive language rapidly expands, and it typically resolves without intervention. Therefore, no specialized referrals or testing are warranted.

Adım Adım Çözüm

1
Analyze the child's current age and reported deficits.
The child is exactly 4 years old. The parents report an inability to tie shoelaces, an inability to copy a triangle, and episodic stuttering (syllable repetition).
Establishing the baseline age is essential for determining which developmental milestones are expected.
2
Compare the reported fine motor deficits to age-appropriate normal milestones.
Tying shoelaces and copying a triangle are milestones expected at age 5. The child successfully buttons his shirt and copies a cross, which strictly align with normal 4-year-old fine motor milestones.
Differentiating between milestones of contiguous ages (4 vs. 5 years) prevents over-diagnosing developmental delay.
3
Evaluate the speech dysfluency characteristics.
The boy has 100% intelligible speech with isolated syllable repetition, lacking secondary behaviors such as facial grimacing, eye blinking, or frustration.
This presentation defines normal developmental dysfluency, which peaks between ages 2 and 5 and resolves spontaneously, contrasting with pathologic stuttering.
4
Determine the appropriate clinical intervention based on the assessment.
Because all motor, social, and language findings are normal or benign variations for a 4-year-old, no referrals are necessary. Reassurance is indicated.
Unnecessary referrals can induce parental anxiety and waste medical resources when a child is on a normal developmental trajectory.

Anahtar Kavram

Differentiation between 4-year-old and 5-year-old developmental milestones, and the recognition of benign developmental dysfluency.
Soru 2115Soru →

A 54-year-old woman presents to the outpatient clinic reporting a three-week history of progressively worsening exertional dyspnea, fatigue, and bilateral lower extremity swelling. She states that she now requires three pillows to sleep comfortably at night without waking up short of breath. Her medical history is significant for estrogen-receptor-negative, HER2-positive breast cancer, for which she underwent surgical resection and completed a chemotherapy regimen containing doxorubicin and cyclophosphamide six months ago. She is currently receiving maintenance therapy with trastuzumab. Vital signs show a temperature of 37.1∘C37.1^\circ C (98.8∘F98.8^\circ F), heart rate of 105 /min105\text{ /min}, respiratory rate of 22 /min22\text{ /min}, and blood pressure of 114/74 mmHg114/74\text{ mmHg}. Pulse oximetry is 94%94\% on room air. Physical examination reveals an elevated jugular venous pressure of 9 cm H2O9\text{ cm H}_2\text{O}, fine bibasilar crackles, and a distinct third heart sound (S3S_3). Pitting edema is present to the mid-calves bilaterally.

Recent laboratory studies are as follows:

Laboratory TestPatient ResultReference Range
Thyroid-stimulating hormone (TSH)2.2 μU/mL2.2\text{ }\mu\text{U/mL}0.5−5.0 μU/mL0.5-5.0\text{ }\mu\text{U/mL}
Arterial pHpH7.467.467.35−7.457.35-7.45
Arterial pCO2pCO_231 mmHg31\text{ mmHg}35−45 mmHg35-45\text{ mmHg}
Arterial pO2pO_270 mmHg70\text{ mmHg}75−105 mmHg75-105\text{ mmHg}

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Transthoracic echocardiography

Cevap

The most appropriate next step in management is to perform a transthoracic echocardiography.
The correct answer is transthoracic echocardiography because this patient exhibits classic signs and symptoms of acute decompensated heart failure (orthopnea, elevated JVP, S3 gallop, pulmonary crackles, and peripheral edema). Her recent treatment with doxorubicin (an anthracycline) and ongoing treatment with trastuzumab place her at an exceptionally high risk for chemotherapy-induced cardiotoxicity. Doxorubicin causes dose-dependent, irreversible myocyte necrosis leading to dilated cardiomyopathy, while trastuzumab causes a usually reversible decline in contractility. Echocardiography is the essential next step to evaluate the left ventricular ejection fraction (LVEF) and guide subsequent heart failure management.

Adım Adım Çözüm

1
Identify the patient's primary clinical syndrome.
The patient presents with progressive dyspnea, orthopnea, elevated jugular venous pressure, an S3 gallop, and bilateral lower extremity edema, which are hallmark signs of acute decompensated heart failure.
Recognizing the pattern of volume overload and pump failure is required to differentiate this from primary pulmonary or endocrine pathologies.
2
Assess the patient's risk factors based on her oncologic history.
The patient received doxorubicin (an anthracycline) and is currently taking trastuzumab (a HER2 monoclonal antibody). Both are known to be highly cardiotoxic.
Anthracyclines cause dose-dependent, irreversible myocyte necrosis, while trastuzumab causes a typically reversible decline in myocardial contractility. The combination significantly amplifies the risk of dilated cardiomyopathy.
3
Determine the best diagnostic test to confirm the suspected etiology.
Transthoracic echocardiography should be ordered.
Echocardiography is the gold standard, non-invasive initial test to evaluate left ventricular ejection fraction (LVEF), structural abnormalities, and confirm the diagnosis of chemotherapy-induced cardiomyopathy.

Anahtar Kavram

Patients treated with cardiotoxic chemotherapeutic agents (e.g., anthracyclines, trastuzumab) who present with signs of volume overload must be promptly evaluated for chemotherapy-induced cardiomyopathy using transthoracic echocardiography.
Soru 2116Soru →

A 24-year-old woman is brought to the emergency department by her roommate 2 hours after intentionally ingesting a large, unknown quantity of immediate-release acetaminophen tablets. She reports mild nausea but is otherwise asymptomatic. Her temperature is 37.0°C (98.6°F), blood pressure is 118/76 mm Hg, pulse is 88/min, and respirations are 14/min. She is alert, fully oriented, and cooperative. Arrange the following steps in the most appropriate chronological sequence for the evaluation and management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Administer oral activated charcoal, 2) Measure the serum acetaminophen concentration at 4 hours post-ingestion, 3) Determine hepatotoxicity risk using the Rumack-Matthew nomogram, 4) Initiate treatment with N-acetylcysteine if the treatment line is crossed.
The clinical management of acute immediate-release acetaminophen overdose depends heavily on the time since ingestion. Because this patient presented 2 hours post-ingestion and has a normal mental status, the first priority is gastrointestinal decontamination with oral activated charcoal, which is highly effective if given within 4 hours of ingestion. Next, a serum acetaminophen concentration must be obtained, but this should not be drawn until exactly 4 hours post-ingestion; levels drawn earlier are uninterpretable as peak absorption has not yet occurred. Once the 4-hour level is resulted, it is plotted against the time since ingestion on the Rumack-Matthew nomogram. If the plotted point falls on or above the established treatment line, the patient is at risk for severe hepatotoxicity, and the definitive antidote, N-acetylcysteine (NAC), must be administered. Because NAC is nearly 100% effective at preventing liver injury when given within 8 hours of ingestion, it is safe to wait for the 4-hour level before initiating therapy in early presenters.

Adım Adım Çözüm

1
Assess the patient's airway, breathing, circulation, and mental status.
The patient has stable vital signs and is alert and cooperative, indicating that she can safely protect her airway.
Ensuring airway protection is the essential first step in any toxicology patient before administering oral decontamination therapies.
2
Determine the indication for gastrointestinal decontamination.
Oral activated charcoal is administered because the patient presented within 4 hours of an acute ingestion.
Activated charcoal binds unabsorbed acetaminophen in the gastrointestinal tract and limits systemic absorption.
3
Determine the precise timing for biochemical risk stratification.
A serum acetaminophen level is ordered to be drawn exactly at 4 hours post-ingestion.
Levels drawn before 4 hours are uninterpretable because systemic absorption and tissue distribution are not yet complete.
4
Stratify risk and determine the need for definitive antidote therapy.
The 4-hour level is plotted on the Rumack-Matthew nomogram, and N-acetylcysteine is initiated if the level indicates a high risk of hepatotoxicity.
The nomogram provides an evidence-based threshold for giving the antidote, which is maximally effective when administered within 8 hours of ingestion.

Anahtar Kavram

In the acute management of immediate-release acetaminophen overdose presenting within 4 hours, the correct sequence involves initial gastrointestinal decontamination with activated charcoal (if the airway is intact), followed by measuring the serum acetaminophen level at 4 hours post-ingestion, risk-stratifying with the Rumack-Matthew nomogram, and administering N-acetylcysteine if indicated.
Soru 2117Soru →

A family physician is reviewing the timeline for universal screening tests recommended during routine well-child care. Arrange the following universal screening evaluations in chronological order based on the earliest age they are routinely indicated for healthy children.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: Newborn hearing screening (Birth), Standardized autism-specific screening (18 months), Visual acuity testing with optotypes (4 years), and Universal major depressive disorder screening (12 years).
The correct chronological sequence reflects the standard well-child care timeline. Hearing screening is prioritized at birth to prevent language delay. Autism screening is performed at 18 and 24 months when social-communicative deficits become apparent. Vision acuity testing using optotypes requires patient cooperation, which is typically achieved by age 4. Depression screening begins at age 12, corresponding with the onset of adolescence.

Adım Adım Çözüm

1
Identify the recommended age for newborn hearing screening.
It is performed at birth.
To ensure early intervention for congenital hearing loss.
2
Identify the recommended age for standardized autism screening.
It is performed at 18 and 24 months.
Signs of autism typically become reliably evident by this age.
3
Identify the recommended age for visual acuity testing using optotypes.
It begins universally at age 4 years.
Children reach the cognitive ability to follow chart instructions.
4
Identify the recommended age for universal depression screening.
It begins at 12 years.
Adolescence is a high-risk period for the onset of major depressive disorder.

Anahtar Kavram

The American Academy of Pediatrics recommends a specific timeline for universal well-child screenings, including hearing at birth, autism at 18 and 24 months, visual acuity at 4 years, and depression starting at 12 years.
Tahmini Süre:1m 0s
Soru 2118Soru →

Progressive shortness of breath over the past 48 hours prompts a 62-year-old man to seek evaluation at the emergency department. He has a 45-pack-year smoking history, type 2 diabetes mellitus, and essential hypertension. The patient notes that his breathing worsens significantly when he lies flat, forcing him to sleep in a recliner chair. His temperature is 37.2°C (99.0°F), blood pressure is 162/94 mm Hg, pulse is 108/min, and respiratory rate is 24/min. Pulse oximetry shows an oxygen saturation of 90% on room air. Physical examination reveals distended neck veins while sitting at a 45-degree angle. Lung auscultation demonstrates bilateral basilar crackles without wheezing. Cardiac examination reveals a regular tachycardia with a prominent S3 gallop. A chest radiograph demonstrates cardiomegaly and cephalization of pulmonary vessels. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Acute decompensated heart failure

Cevap

The correct answer is acute decompensated heart failure.
The correct answer is acute decompensated heart failure. This patient presents with a classic constellation of symptoms and signs of acute biventricular heart failure. His orthopnea, bilateral basilar crackles, and S3 gallop indicate left-sided fluid overload and elevated left ventricular end-diastolic pressure. The jugular venous distention indicates right-sided fluid overload. Finally, the chest radiograph findings of cardiomegaly and cephalization (pulmonary venous congestion) definitively confirm the diagnosis over primary pulmonary pathologies.

Adım Adım Çözüm

1
Identify the primary clinical syndrome based on the history.
The patient presents with acute, progressively worsening dyspnea and severe orthopnea (needing to sleep in a recliner).
Recognizing orthopnea strongly suggests a cardiogenic etiology for the dyspnea due to central fluid redistribution when supine.
2
Analyze the physical examination findings for diagnostic clues.
The exam shows jugular venous distention (right-sided fluid overload), bilateral basilar crackles (alveolar fluid), and an S3 gallop (rapid ventricular filling in a non-compliant, overloaded left ventricle).
These findings collectively indicate biventricular volume overload, distinguishing it from purely pulmonary causes of dyspnea.
3
Correlate clinical findings with the provided imaging results.
The chest radiograph shows cardiomegaly and cephalization (redistribution of blood flow to the upper lung zones).
This confirms the presence of pulmonary venous hypertension secondary to left heart failure, establishing the definitive diagnosis.

Anahtar Kavram

Diagnosis of acute decompensated heart failure hinges on identifying signs of left-sided (orthopnea, crackles, S3 gallop, cephalization) and right-sided (JVD) volume overload.
Tahmini Süre:1m 0s
Soru 2119Soru →

A 65-year-old woman with a body mass index (BMI) of 32 kg/m232\text{ kg/m}^2 is diagnosed with osteoarthritis of the right knee after presenting with chronic, progressive knee pain that worsens with activity. Radiographs show joint space narrowing and osteophyte formation. Arrange the following management strategies in the standard chronological order of escalation, from initial conservative therapy to definitive treatment.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of escalating management for knee osteoarthritis begins with non-pharmacological interventions (weight loss and physical therapy), followed by first-line pharmacological therapy (NSAIDs), then intra-articular therapies (glucocorticoid injections), and finally surgical intervention (total knee arthroplasty) for refractory disease.
Osteoarthritis is managed in a stepwise fashion to minimize patient risk while maximizing symptom relief and function. Management begins with lifestyle and non-pharmacologic interventions (weight loss, exercise). If symptoms persist, first-line pharmacologic agents (topical or oral NSAIDs) are added. For continued refractory pain, localized interventions like intra-articular glucocorticoid injections are utilized. When all conservative and medical therapies fail and the patient's quality of life is severely impacted, definitive surgical management (total joint arthroplasty) is indicated.

Adım Adım Çözüm

1
Identify the foundational first step for osteoarthritis management.
Weight loss, physical therapy, and low-impact exercise.
Lifestyle modifications provide significant symptom relief with minimal risk and form the basis of all osteoarthritis treatment, particularly in patients with an elevated BMI.
2
Determine the first-line escalation for persisting symptoms.
Oral or topical nonsteroidal anti-inflammatory drugs (NSAIDs).
Pharmacotherapy is introduced when lifestyle changes are insufficient. NSAIDs are the initial medications of choice.
3
Identify the next step for localized pain refractory to initial medications.
Intra-articular glucocorticoid injections.
When systemic or topical medications fail to control symptoms, targeted intra-articular injections can provide significant relief and delay the need for surgery.
4
Select the definitive treatment for end-stage, refractory disease.
Total knee arthroplasty.
Surgical intervention is considered the final step in the treatment pathway, reserved for patients who have exhausted all conservative and medical options and still have unacceptable pain and functional limitation.

Anahtar Kavram

Stepwise management of osteoarthritis
Soru 2120Soru →

A pediatric clinic evaluates several patients presenting for routine health maintenance or parent concerns regarding growth and development. Match each patient's clinical presentation with the most accurate clinical interpretation and next best step in management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 9-month-old boy, born at 28 weeks gestation, who sits without support, transfers objects hand-to-hand, and babbles, but does not yet pull to stand or exhibit a pincer grasp.
A 16-month-old boy who walks independently, builds a 2-cube tower, and uses 3 distinct words, but consistently fails to point at objects to share interest with his parents.
A 24-month-old girl whose length crossed two major percentiles downward between ages 6 and 18 months and now tracks along the 10th percentile; her weight is at the 25th percentile, and her calculated mid-parental target height is at the 10th percentile.
A 14-month-old boy whose weight has steadily declined from the 50th to the 5th percentile over the past 6 months, while his length has remained tracking at the 40th percentile.
A 7-year-old girl who presents with bilateral breast bud development and an absence of pubic hair, whose radiographic bone age is determined to be exactly congruent with her chronological age.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Patient 1 corresponds to normal corrected development; Patient 2 corresponds to autism red flags; Patient 3 corresponds to normal shifting to genetic potential; Patient 4 corresponds to inadequate caloric intake; Patient 5 corresponds to isolated premature thelarche.
Each vignette represents a highly specific presentation requiring synthesis of distinct developmental and growth principles. Adjusting the premature infant's age from 9 months to 6 months normalizes his milestones. The 16-month-old's isolated lack of pointing indicates a deficit in joint attention, a hallmark of autism. The 24-month-old's growth curve stabilizing at the mid-parental height reflects normal genetic variance. The 14-month-old's weight-only drop is the classic signature of malnutrition. The 7-year-old's normal bone age confirms her thelarche is an isolated, benign variant.

Adım Adım Çözüm

1
Analyze the 9-month-old premature boy.
Calculated corrected age is 6 months. Milestones presented perfectly match 6-month norms, excluding developmental delay.
Premature infants must have their developmental milestones assessed based on their corrected age until they reach 24 months.
2
Evaluate the 16-month-old boy with absent pointing.
Identified the lack of pointing to share interest as a profound deficit in joint attention.
Failure to point by 15 months is a critical early marker for autism spectrum disorder, overriding his normal gross motor skills.
3
Assess the 24-month-old girl's growth trajectory.
Correlated her downward shift in length percentiles with her 10th percentile mid-parental target height.
Normal shifting to genetic target height typically occurs between 6 and 18 months of age and then stabilizes, unlike pathologic growth failure.
4
Analyze the 14-month-old boy's growth faltering.
Noted an asymmetric growth failure where weight dropped significantly while length was preserved.
Nutritional deficiency (inadequate caloric intake) classically affects weight first, then length, then head circumference.
5
Evaluate the 7-year-old girl with early breast development.
Synthesized the presence of thelarche with the normal bone age to rule out central precocious puberty.
Isolated premature thelarche is a benign condition characterized by a normal bone age; advanced bone age would indicate a pathologic precocious puberty.

Anahtar Kavram

Mastery of pediatric development requires distinguishing normal variants (shifting to genetic potential, isolated thelarche) from pathologic states (caloric malnutrition, precocious puberty, autism spectrum disorders) while strictly adjusting for prematurity.
ÖncekiSayfa 106 / 414Sonraki
Tüm alıştırma soruları — USMLE Step 2 CK | Examkin